|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 165.5 SEK | +0.49% |
|
+4.42% | +23.78% |
| Apr. 25 | Transcript : Biotage AB, Q1 2024 Earnings Call, Apr 25, 2024 | |
| Apr. 25 | Biotage AB Approves a Dividend, Payable on May 3, 2024 | CI |
Biotage AB (publ) reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was SEK 361 million compared to SEK 386 million a year ago. Net income was SEK 43 million compared to SEK 71 million a year ago.
Basic earnings per share from continuing operations was SEK 0.65 compared to SEK 1.08 a year ago. Diluted earnings per share from continuing operations was SEK 0.65 compared to SEK 1.08 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +23.78% | 1.21B | |
| -12.91% | 19.08B | |
| -46.21% | 2.65B | |
| +18.15% | 1.87B | |
| -3.12% | 1.61B | |
| -10.69% | 1.02B | |
| -20.89% | 905M | |
| -7.14% | 716M | |
| -18.10% | 682M | |
| +4.01% | 480M |
BIOTAGE AB 
